Search for content, post, videos

EXACT Therapeutics presents encouraging data

The company has presented data from two patients with liver metastases of colorectal cancer origin treated with ACT in the clinical Phase I ACTIVATE trial. The presented radiological results from these two patients suggest an improved response to standard of care chemotherapy in the tumors that a
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.